|
gptkbp:instance_of
|
gptkb:chemical_compound
|
|
gptkbp:affects
|
gptkb:computer
|
|
gptkbp:chemical_formula
|
C20 H25 N3 O
|
|
gptkbp:composed_by
|
cannabinoid precursors
|
|
gptkbp:developed_by
|
gptkb:University_of_California
|
|
gptkbp:discovered_by
|
2000s
|
|
gptkbp:dissolved
|
gptkb:dimethyl_sulfoxide
ethanol
|
|
gptkbp:has_a_molecular_weight
|
311.44 g/mol
|
|
gptkbp:has_impact_on
|
pain relief
anxiety reduction
anti-inflammatory properties
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
AM-43
|
|
gptkbp:is_a_derivative_of
|
gptkb:anandamide
|
|
gptkbp:is_analyzed_in
|
cannabinoid receptors
|
|
gptkbp:is_insoluble_in
|
gptkb:water
|
|
gptkbp:is_involved_in
|
immune response
neuroprotection
pain modulation
|
|
gptkbp:is_not_approved_for
|
medical use
|
|
gptkbp:is_related_to
|
endocannabinoid system
|
|
gptkbp:is_studied_for
|
therapeutic applications
|
|
gptkbp:melting_point
|
not specified
|
|
gptkbp:previous_name
|
(2 S)-N-[(1 S)-1-(4-methylphenyl)ethyl]-2-(4-morpholinyl)propanamide
|
|
gptkbp:related_to
|
gptkb:cannabidiol
gptkb:tetrahydrocannabinol
|
|
gptkbp:scientific_classification
|
research chemical
|
|
gptkbp:sensitivity
|
gptkb:light
moisture
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:targets
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:treatment
|
gptkb:Ophthalmology
gptkb:Crohn's_disease
gptkb:ulcerative_colitis
gptkb:epilepsy
gptkb:juvenile_idiopathic_arthritis
gptkb:neurodegenerative_diseases
gptkb:multiple_sclerosis
nausea
chronic pain
sleep disorders
anxiety disorders
traumatic brain injury
PTSD
Tourette syndrome
fibromyalgia
inflammatory diseases
spinal cord injury
autism spectrum disorders
appetite stimulation
stroke recovery
HIV/ AIDS-related symptoms
cancer-related symptoms
|
|
gptkbp:type
|
gptkb:FA_Cup
|
|
gptkbp:used_in
|
gptkb:research
|